Drug-induced parkinsonism after allogeneic bone marrow transplantation
Pavletic, Z.S.; Bishop, M.R.; Markopoulou, K.; Wszolek, Z.K.
Bone Marrow Transplantation 17(6): 1185-1187
1996
ISSN/ISBN: 0268-3369 PMID: 8807135 Document Number: 461865
We report a severe case of drug-induced parkinsonism (DIP) after allogeneic BMT successfully treated with levodopa. BMT patients typically receive numerous medications which can cause DIP, and mild cases of DIP may remain unrecognized or be misdiagnosed. Physicians should be aware of DIP as a potential neurological complication after BMT to avoid further administration of drugs that could aggravate symptoms.
Document emailed within 1 workday
Related Documents
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Marmont, A.M. 1979: Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia Nouvelle Revue Francaise d'Hematologie 21(2): 133-148
Merino, A.; Urbano-Ispizua, A.; Marín, P.; Besson, I.; Carreras, E.; Sierra, J.; Salgado, C.; Rovira, M.; Grañena, A.; Montserrat, E. 1993: Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation Sangre 38(5): 359-364
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Slavin, S.; Nagler, A. 1997: Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants Cancer Journal from Scientific American 3(Suppl 1): S59-S67
De Witte, T.; Schattenberg, A.; Preijers, F.; Raymakers, R.; Muus, P.; Wessels, J. 1993: Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation Bone Marrow Transplantation 12(Suppl 3): S2-S6
Fay, J.W.; Collins, R.H.; Piñeiro, L. 1993: Allogeneic bone marrow transplantation using unrelated marrow donors Bone Marrow Transplantation 11(Suppl 1): 81-82
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Rozman, C.; Grañena, A.; Marín, P.; Hernández-Prieto, M.; Nomdedeu, B.; Montserrat, E.; Feliu, E.; Bladé, J.; Cervantes, F.; Vives Corrons, J.L. 1985: Allogeneic marrow transplantation in severe bone marrow aplasia. Factors determining the outcome in a series of 27 consecutive cases Medicina Clinica 84(4): 129-134
Stockschläder, M.; Krüger, W.; Kroschke, G.; Zeller, W.; Hoffknecht, M.; Löliger, C.; Kabisch, H.; Zander, A. 1995: Use of cryopreserved bone marrow in allogeneic bone marrow transplantation Bone Marrow Transplantation 15(4): 569-572
Santos, G.W. 1992: Allogeneic and autologous bone marrow transplantation in AML Leukemia 6(Suppl 2): 102-103
Marmont, A.M. 1993: New frontiers for allogeneic bone marrow transplantation Bone Marrow Transplantation 11(Suppl 1): 3-10
Vellodi, A.; Cragg, H.; Winchester, B.; Young, E.; Young, J.; Downie, C.J.; Hoare, R.D.; Stocks, R.; Banerjee, G.K. 1995: Allogeneic bone marrow transplantation for fucosidosis Bone Marrow Transplantation 15(1): 153-158
Tzeng, C.H.; Chen, P.M.; Chiu, C.F.; Chiou, T.J.; Hsien, R.K.; Chuang, M.W.; Chen, K.Y.; Yung, C.H.; Wang, S.Y.; Wang, S.R. 1987: HLA-mismatched allogeneic bone marrow transplantation Zhonghua Yi Xue Za Zhi 39(3): 187-196
Klingemann, H.G.; Storb, R. 1985: Cyclosporin in allogeneic bone marrow transplantation Der Internist 26(9): 569-574
Prentice, H.G. 1987: T cell depletion in allogeneic bone marrow transplantation Transplantation Proceedings 19(1 Part 1): 155-156